Does chlorthalidone cause hair loss? This is a question raised by some patients taking this thiazide-like diuretic for hypertension or oedema. Chlortalidone (the UK-approved spelling) is recommended in NICE guideline NG136 and is widely used in UK primary care. Whilst hair loss is not a recognised or commonly listed side effect in the Summary of Product Characteristics or BNF, a small number of anecdotal reports have prompted concern. This article examines the available evidence, explores possible mechanisms, and explains what to do if you notice hair thinning whilst taking chlortalidone.

Chlortalidone and Hair Loss: What the Evidence Shows

Hair loss is not a recognised side effect of chlortalidone in the SmPC, BNF, or MHRA/EMA data, and no established causal link exists based on current clinical evidence.

Experiencing these side effects? Our pharmacists can help you navigate them →

Chlortalidone (also known as chlorthalidone) is a thiazide-like diuretic recommended in NICE guideline NG136 (Hypertension in adults) as an option for the management of hypertension and oedema. It works by reducing the reabsorption of sodium and chloride in the distal convoluted tubule of the kidney, thereby promoting the excretion of water and lowering blood pressure. It is considered an effective and well-tolerated antihypertensive agent, as reflected in the BNF and NICE NG136.

When it comes to hair loss, the evidence is limited and largely anecdotal. Hair loss (alopecia) does not appear as a commonly listed side effect in the Summary of Product Characteristics (SmPC) for chlortalidone (available via the MHRA/EMC), nor is it prominently flagged by the Medicines and Healthcare products Regulatory Agency (MHRA) or the European Medicines Agency (EMA) as a recognised adverse reaction. That said, a small number of case reports and patient accounts have raised the question of whether chlortalidone may contribute to hair thinning in some individuals.

It is important to note that there is no established, officially recognised causal link between chlortalidone and hair loss based on current clinical evidence. Any association observed in individual patients may reflect coincidence, underlying health conditions, or the use of concurrent medications. Patients who notice hair changes whilst taking chlortalidone should not discontinue the medication without first speaking to their GP or prescribing clinician, as abrupt cessation can have implications for blood pressure control.

If you suspect chlortalidone may be causing a side effect, you can report this to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk or through the Yellow Card app. Reporting suspected adverse drug reactions helps the MHRA monitor the safety of medicines in the UK.

How Thiazide-Like Diuretics May Affect Hair Growth

Chlortalidone can cause electrolyte losses, and theoretically micronutrient depletion could trigger telogen effluvium, but this mechanism is speculative and unconfirmed in clinical studies.

To understand why chlortalidone is sometimes associated with hair concerns, it is helpful to consider how diuretics interact with the body's physiology. Chlortalidone, like other thiazide and thiazide-like diuretics, can influence the balance of key electrolytes — particularly potassium, sodium, and magnesium — through increased urinary excretion; these effects are well documented in the BNF and the chlortalidone SmPC. There is also theoretical interest in whether zinc levels may be affected, as zinc plays a role in supporting the hair follicle cycle and deficiency has been linked to telogen effluvium. However, zinc depletion with thiazide-like diuretics is not well established in the clinical literature, and this mechanism should be regarded as speculative rather than confirmed.

Worried about interactions with other medications? Speak to one of our pharmacists →

Telogen effluvium occurs when a physiological stressor — whether nutritional, hormonal, or pharmacological — causes a disproportionate number of hair follicles to enter the resting (telogen) phase simultaneously, resulting in noticeable shedding typically two to three months after the triggering event. If chlortalidone were to contribute to micronutrient depletion over time, this could theoretically create conditions that predispose susceptible individuals to hair thinning — but this remains a theoretical mechanism and has not been confirmed in robust clinical studies.

Some sources suggest that diuretics may cause mild dehydration if fluid intake is not maintained, and that this could affect scalp and hair shaft health. This too is speculative and not supported by direct clinical evidence.

Standard monitoring for patients on chlortalidone in UK primary care focuses on renal function and electrolytes (particularly potassium and sodium). Micronutrient testing — for example, zinc or vitamin D — should be guided by clinical suspicion rather than undertaken routinely. Patients concerned about nutritional deficiencies whilst on long-term diuretic therapy should discuss this with their GP.

How Common Is Hair Loss With Chlortalidone?

Hair loss is not considered a common or well-established side effect of chlortalidone, and no notable alopecia signal was reported in the large-scale ALLHAT trial.

Based on available prescribing information and pharmacovigilance data, hair loss is not considered a common or well-established side effect of chlortalidone. The recognised adverse effects of chlortalidone, as listed in the BNF and the MHRA/EMC SmPC, include:

• Electrolyte disturbances (hypokalaemia, hyponatraemia, hypomagnesaemia)

• Increased blood glucose and potential worsening of diabetes

• Raised uric acid levels, which may precipitate gout

• Postural hypotension, particularly in older adults

• Increased urinary frequency, especially in the initial weeks of treatment

Hair loss does not feature prominently in large-scale clinical trials of chlortalidone. In the ALLHAT trial (JAMA, 2002), which enrolled over 33,000 participants, no notable signal for alopecia was reported in the published adverse event data, and chlortalidone demonstrated a favourable cardiovascular safety profile. It should be noted that ALLHAT was conducted in the United States, and its adverse event reporting may not have captured all dermatological outcomes systematically.

Individual variation in drug response is well recognised in clinical practice. Some patients may be more susceptible to hair changes due to genetic predisposition, pre-existing nutritional deficiencies, hormonal factors, or concurrent health conditions such as thyroid disease. The frequency of hair loss attributable specifically to chlortalidone — as opposed to these confounding factors — is therefore very difficult to quantify. If hair loss is a concern, a structured clinical assessment is far more informative than attributing the symptom to any single medication without investigation.

Other Medications and Factors That Can Cause Hair Loss

Beta-blockers, anticoagulants, and antithyroid medications have a more established association with alopecia than chlortalidone, and systemic conditions such as thyroid disease and iron deficiency are common confounders.

Before attributing hair loss to chlortalidone, it is essential to consider the broader clinical picture. Many patients prescribed chlortalidone are also taking other medications for cardiovascular or metabolic conditions, some of which have a more established association with alopecia. These include:

• Beta-blockers (e.g., bisoprolol, propranolol, atenolol) — associated with telogen effluvium

• ACE inhibitors and angiotensin receptor blockers (ARBs) — rare reports of hair thinning exist in the literature

• Statins — rare reports of alopecia have been described

• Anticoagulants such as warfarin or heparin — known to cause hair shedding

• Antithyroid medications and oral contraceptives — well-documented causes

The strength of association varies considerably across these drug classes; for ACE inhibitors, ARBs, and statins, reports are uncommon or rare. The BNF and individual SmPCs provide further detail on the frequency of these adverse effects.

Beyond medications, a range of systemic and lifestyle factors can contribute to hair loss, including hypothyroidism or hyperthyroidism, iron deficiency anaemia, polycystic ovary syndrome (PCOS), significant psychological or physical stress, rapid weight loss, and nutritional deficiencies (particularly iron and ferritin). Age-related androgenetic alopecia is also extremely common in both men and women and may coincide with the initiation of antihypertensive therapy simply due to timing.

A thorough assessment by a GP — including a detailed medication review and targeted blood tests — is the most reliable way to identify the underlying cause of hair loss. The NHS and NICE Clinical Knowledge Summary (CKS) on alopecia provide useful guidance on assessment and management. Assuming chlortalidone is responsible without ruling out these other factors could lead to unnecessary medication changes and suboptimal blood pressure management.

What to Do If You Notice Hair Thinning on Chlortalidone

Speak to your GP rather than stopping chlortalidone independently; a medication review and targeted blood tests are the most reliable way to identify the underlying cause of hair thinning.

If you have started noticing hair thinning or increased shedding whilst taking chlortalidone, the most important first step is to speak to your GP rather than stopping the medication independently. Chlortalidone plays an important role in managing blood pressure, and discontinuing it without medical supervision could increase your risk of cardiovascular events.

Seek prompt GP review if you notice any of the following red flags:

• Scalp pain, redness, scaling, or pustules (which may suggest a scarring or inflammatory cause)

• Rapidly progressive or widespread hair loss

• Patchy hair loss, particularly in children

• Hair loss accompanied by systemic symptoms (e.g., fatigue, weight change, or skin changes)

• Features that may suggest hyperandrogenism (e.g., irregular periods, acne, or unwanted facial hair in women)

These features may warrant more urgent assessment or referral to a dermatologist.

For most patients, your GP may recommend the following approach:

• A detailed medication review to identify any other drugs that may be contributing to hair loss

• Initial blood tests, typically including full blood count (FBC), serum ferritin, and thyroid function (TSH); further tests such as vitamin B12, folate, vitamin D, zinc, magnesium, or an androgen profile may be considered if the history or examination suggests a specific cause

• Assessment of blood pressure control to determine whether a medication change is clinically appropriate

• Referral to a dermatologist if the cause remains unclear, if hair loss is significant and distressing, or if red flag features are present

In many cases, hair loss may resolve once an underlying deficiency is identified and treated, or once the body adjusts to the medication. If a genuine drug-induced cause is suspected and confirmed, your GP may consider switching to an alternative antihypertensive agent, though this decision must always be balanced against cardiovascular risk.

From a self-care perspective, maintaining a balanced diet rich in protein and iron, staying well hydrated, and managing stress can all support hair health. Avoid aggressive hair treatments or tight hairstyles during periods of shedding. The NHS website provides further information on hair loss and when to seek help. If you believe chlortalidone may be responsible for a side effect, please report it to the MHRA via the Yellow Card Scheme at yellowcard.mhra.gov.uk — your report contributes to ongoing medicine safety monitoring in the UK.

Frequently Asked Questions